sample is physically larger, any mechanical errors in post-expansion sectioning, or stage drift, are divided by the expansion factor.
Replication-transcription switch in human mitochondria
Karen Agaronyan, Yaroslav I. Morozov, Michael Anikin, Dmitry Temiakov* Coordinated replication and expression of the mitochondrial genome is critical for metabolically active cells during various stages of development. However, it is not known whether replication and transcription can occur simultaneously without interfering with each other and whether mitochondrial DNA copy number can be regulated by the transcription machinery.We found that interaction of human transcription elongation factor TEFM with mitochondrial RNA polymerase and nascent transcript prevents the generation of replication primers and increases transcription processivity and thereby serves as a molecular switch between replication and transcription, which appear to be mutually exclusive processes in mitochondria. TEFM may allow mitochondria to increase transcription rates and, as a consequence, respiration and adenosine triphosphate production without the need to replicate mitochondrial DNA, as has been observed during spermatogenesis and the early stages of embryogenesis.
T he maternally inherited circular mitochondrial DNA (mtDNA) encodes subunits of complexes of the oxidative phosphorylation chain, as well as transfer RNAs (tRNAs) and ribosomal RNAs (1, 2) . Transcription of human mtDNA is directed by two promoters, the LSP (light-strand promoter) and the HSP (heavystrand promoter) located in opposing mtDNA strands, which results in two almost-genomesized polycistronic transcripts that undergo extensive processing before polyadenylation and translation (3, 4) . Note that transcription terminates prematurely about 120 base pairs (bp) downstream of LSP at a vertebrate-conserved G-rich region, called conserved sequence block II (CSBII), as a result of formation of a hybrid G-quadruplex between nascent RNA and the nontemplate strand of DNA (5-7). This termination event occurs near the origin of replication of the heavy strand (oriH) (8) and generates a replication primer. According to the asymmetric model (9) , replication then proceeds through about two-thirds of the mtDNA, until the oriL sequence in the opposing strand becomes single stranded and forms a hairpin structure. The oriL hairpin is then recognized by mitochondrial RNA polymerase (mtRNAP), which primes replication of the light strand (10) . Because replication of mtDNA coincides with transcription in time and space, collisions between transcription and replication machineries are inevitable and, similarly to bacterial and eukaryotic systems, likely have detrimental effects on mtDNA gene expression (11) .
We analyzed the effects of a mitochondrial transcription elongation factor, TEFM, recently described by Minczuk and colleagues (12) , on transcription of mtDNA. This protein was pulled down from mitochondrial lysates via mtRNAP and was found to stimulate nonspecific transcription on promoterless DNA; however, its effect on promoter-driven transcription had not been determined (12) . We found that in the presence of TEFM, mtRNAP efficiently transcribes through CSBII (Fig. 1, A and B) . Thus, TEFM acts as a factor that prevents termination at CSBII and synthesis of a primer for mtDNA polymerase. We identified the exact location of the termination point in CSBII ( fig. S1 ). MtRNAP terminates at the end of a U6 sequence (positions 287 to 283 in mtDNA), 16 to 18 nucleotides (nt) downstream of the G-quadruplex (Fig. 1A) . At this point, the 9-bp RNA-DNA hybrid in the elongation complex (EC) is extremely weak, as it is composed of only A-U and T-A pairs. This is reminiscent of intrinsic termination signals in prokaryoteswhere the formation of an RNA hairpin is thought to disrupt the upstream region of the RNA-DNA hybrid-and is followed by the run of six to eight uridine 5′-monophosphate residues that further destabilizes the complex (5, 13) .
Human mtDNA is highly polymorphic in the CSBII region; coincidently, the reference mitochondrial genome (Cambridge) contains a rare polymorphism in the G-quadruplex-namely, G5AG7-whereas the majority of mtDNAs from various haplogroups have two additional G residues (G6AG8) (14) . We found that the termination efficiency of mtRNAP was substantially lower at G5AG7-CSBII (Fig. 1C) , which suggested an effect of G run length on quadruplex formation and underscored the importance of further studies of various polymorphisms in this region.
In considering a putative mechanism of TEFM antitermination activity, we investigated whether it can interact with the nascent transcript and, thus, interfere with the formation of the quadruplex structure. We assembled ECs on a nucleic acid scaffold containing a photoreactive analog of uridine, 4-thio-uridine, 13 nt downstream from the 3′ end of RNA, and walked mtRNAP along the template by incorporation of appropriate substrate nucleoside triphosphates (NTPs) ( Fig. 2A) . We observed efficient cross-linking between TEFM and RNA when the photoreactive base was 15 to 16 bp away from the 3′ end of RNA. Additionally, using a template DNA containing the LSP promoter and CSBII, we probed interactions of TEFM with RNA having a photoreactive probe 6-thio guanosine-5′-monophosphate (6-thio GMP) 9 to 16 or 18 to 25 nt away from the 3′ end of RNA ( fig. S2 ). We found that TEFM efficiently cross-linked to the G-quadruplex region of RNA, which further confirmed its interactions with the nascent transcript ( fig. S2 ).
The catalytic domains of mtRNAP and the single-subunit RNAP from bacteriophage T7 share high sequence and structural homology (15) . When we compared the structural organization of human mtRNAP EC (15) and T7 RNAP EC (16), one striking difference became apparent-the former polymerase makes very few contacts with the downstream DNA duplex ( fig. S3 ). In contrast, in T7 RNAP EC, the N terminus of the polymerase makes extensive interactions with the entire downstream duplex. These extensive interactions with the downstream DNA may explain the high processivity of T7 RNAP (16) . Because TEFM binds the C terminus of mtRNAP (12), we hypothesized that it may also bind the downstream DNA to compensate for the lack of mtRNAP-DNA interactions. To evaluate this, we incorporated 4-thio-2′-deoxythymidine-5′-monophosphate (4-thio dTMP) into the DNA template in the downstream region and assembled the EC using RNA-DNA scaffolds. We found that TEFM efficiently cross-linked to the +7 and +8 bases in the DNA template strand (Fig. 2B and fig. S4A ). The DNA-TEFM crosslinking was species-specific, as no efficient crosslinking was detected when yeast mtRNAP was used (fig. S4B) .
The binding site of TEFM on mtRNAP has been previously identified in the C-terminal region, between residues 768 and 1230 (12) . These data, taken together with the RNA and DNA cross-linking data, suggest that TEFM likely binds to the palm subdomain of mtRNAP in proximity to the PPR domain and interacts with the emerging RNA transcript (Fig. 2C) . It is therefore likely that TEFM antitermination activity is due to direct interference with the formation of the bulky G-quadruplex structure between the palm subdomain and the PPR domain of mtRNAP or due to the allosteric effect of quadruplex formation on complex stability. Similar mechanisms of antitermination have been suggested for lambda phage antiterminators Q and N and a number of bacterial antiterminators that were shown to interact with both RNAP and its nascent transcript that would otherwise form a hairpin structure (17, 18) .
Because TEFM interacts with the downstream DNA (which may stabilize the EC), we decided to investigate its effect on mtRNAP processivity. We found that the efficiency of runoff synthesis by mtRNAP was low if the size of the product exceeded 500 nt (Fig. 3, A and B) . Indeed, the processivity of mtRNAP was substantially lower than that of a related T7 RNAP (which is known to transcribe large fragments of DNA) and was apparently not sufficient to transcribe a 16,000-bp-long mtDNA. In the presence of TEFM, the efficiency of synthesis of long RNA was significantly increased (Fig. 3, A and B) , which suggested that TEFM indeed acts as a processivity factor, as was originally proposed (12) .
We next probed if TEFM contributes to the stability of the elongating mtRNAP and, as a consequence, to its antitermination activity. To demonstrate this, we halted the EC 35 bp downstream of the promoter start site by omitting one of the substrate NTPs [cytidine 5′-triphosphate (CTP)] (Fig. 3C and fig. S5 ), in the presence or absence of TEFM. After 10 to 40 min, the complexes were chased to allow synthesis of a runoff product. In the absence of TEFM, accumulation of a 35-oligomer RNA product predominated, with little production of runoff, which indicates that the halted EC is unstable, rapidly dissociates and reinitiates, but is inefficiently chased (Fig. 3C and  fig. S5 ). In contrast, in the presence of TEFM, little, if any, of 35-oligomer RNA product accumulates, but more efficient synthesis of full-length products is observed, which indicates that, under these conditions, the EC is stable and may subsequently be extended.
Our in vitro data demonstrate that TEFM increases the overall processivity of ECs. In the absence of TEFM, mtRNAP is unable to efficiently produce long transcripts and, instead, terminates at CSBII, which primes replication of the heavy strand of mtDNA (Fig. 4) . Consistent with this, a knockdown of TEFM in human cells results in a decrease of promoter-distal RNA transcripts (12) . We therefore propose that replication and transcription are mutually exclusive processes in human mitochondria that allow the corresponding machineries to avoid the detrimental consequences of head-on collisions (Fig. 4) . As such, TEFM serves as a molecular switch that would allow the organelles to either replicate the mtDNA and regulate its copy number or to elevate its transcription rates. This switch can be important for a number of developmental processes, such as embryogenesis and spermatogenesis, during which an active transcription of mtDNA is observed without replication (19) (20) (21) (22) (23) (24) (25) . Although TEFM may not be the only factor affecting mtDNA copy number (26) , the proposed mechanism provides a solution to these important biological processes. Further in vivo analysis will be required to address the question as to how this switch is regulated in mitochondria of actively metabolizing cells. Fig. 3 . TEFM increases processivity and stability of mtRNAP EC. (A and B) TEFM increases the EC processivity.Transcription was performed using LSP templates lacking CSBII sequence to generate 500-nt (A) or 1000-nt (B) runoff products. Efficiency of synthesis of 500 nt of RNA in the presence of TEFM is taken as 100%. (C) TEFM increases the EC stability. Complexes halted at +35 in the presence or absence of TEFM were incubated for the times indicated and chased with CTP. Numbers below indicate efficiency of a halted EC extension (%). Fig. 4 . Model for a replication-transcription switch in mitochondria. In the absence of TEFM, mtRNAP initiates transcription at the LSP promoter but terminates at CSBII and produces a 120-nt replication primer at the replication origin oriH.The primer is used by replisome for replication of the heavy strand of mtDNA, during which a separate initiation event involving mtRNAP generates a replication primer at oriL. Because of low processivity, transcription from the HSP does not produce a full-size transcript (bottom left). When TEFM is bound (bottom right), transcription from HSP produces genome-length transcripts. At the same time, LSP-driven transcription is not terminated at CSBII and proceeds to the site of factor-dependent termination (MTERF). 
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Translocator proteins (TSPOs) bind steroids and porphyrins, and they are implicated in many human diseases, for which they serve as biomarkers and therapeutic targets. TSPOs have tryptophan-rich sequences that are highly conserved from bacteria to mammals. Here we report crystal structures for Bacillus cereus TSPO (BcTSPO) down to 1.7 Å resolution, including a complex with the benzodiazepine-like inhibitor PK11195. We also describe BcTSPO-mediated protoporphyrin IX (PpIX) reactions, including catalytic degradation to a previously undescribed heme derivative. We used structure-inspired mutations to investigate reaction mechanisms, and we showed that TSPOs from Xenopus and man have similar PpIX-directed activities. Although TSPOs have been regarded as transporters, the catalytic activity in PpIX degradation suggests physiological importance for TSPOs in protection against oxidative stress.
T he translocator protein (TSPO) is named for its putative roles in the transport of cholesterol, proteins, and porphyrins into mitochondria and elsewhere (1) . TSPO was first identified as a peripheral-type benzodiazepine receptor in mammals (2)-attracting attention because of popular anxiolytic benzodiazepines such as diazepam (Valium)-and the tryptophan-rich sensory protein TspO of photosynthetic bacteria proved to be homologous (3). The sequences of TSPO proteins from diverse organisms are highly conserved in sequence ( fig. S1 ) and also in function; notably, rat TSPO can substitute for the bacterial protein as a negative regulator of photosynthesis gene expression in Rhodobacter sphaeroides (4).
Benzodiazepine-like chemicals, such as PK11195, were found to bind to TSPO and regulate steroid biosynthesis (5), and porphyrins were identified as endogenous ligands of rat TSPO, with highest affinity for protoporphyrin IX (PpIX) (6) . Many following studies have pursued TSPO interactions with cholesterol and PpIX (7, 8) . Most recently, the seeming essentiality of TSPO for steroidogenesis (9) has been challenged by the finding that TSPO1
−/− mice are viable and without defects in steroid hormone biosynthesis (10) , and the presumed role in PpIX transport (11) has been amended by the discovery that bacterial TSPOs catalyze a photooxidative degradation of PpIX (12) . Although the underlying biochemical mechanisms for its activities are not fully understood, TSPO has elicited considerable interest for medicine. Roles for TSPO have been imputed in apoptosis (13) , inflammation (14) , HIV biosynthesis (15), cancer (16), Alzheimer's disease (17) , and cardiovascular diseases (18) . TSPO is a therapeutic target (13, (18) (19) (20) and has proven useful as a positron emission tomography-imaging biomarker (14, 17, 21, 22) .
The translocator protein has been characterized in monomer, dimer, and higher oligomeric states (20) . An electron microscopy structure for TSPO from R. sphaeroides (RsTSPO) revealed a dimer (23) , and a nuclear magnetic resonance structure for a mouse TSPO showed a monomer comprising five transmembrane helices (24) .
We produced recombinant TSPO proteins from several bacterial and vertebrate organisms and found Bacillus cereus TSPO (BcTSPO) suitable for biochemical and structural characterization (see supplementary materials and methods). By size-exclusion chromatography, detergent-extracted BcTSPO exists in at least three different oligomeric states ( fig. S2A ). Apo BcTSPO crystallized from the monomer-dimer fraction ( fig. S2 , C and D) in two different lipidic cubic phase (LCP) conditions and also from the high-oligomer fraction as a detergent micelle; the BcTSPO-PK11195 complex crystallized as a dimer in LCP. A structure obtained by single-wavelength anomalous diffraction analysis from iodinated BcTSPO ( fig. S2E ) was the starting point for native structures that followed (tables S1 and S2). Refinements yielded structures at 1.7 Å (Fig. 1, A to E, and fig. S3 ) and 2.0 Å resolution for apo monomers in LCP, at 4.1 Å resolution for the apo dimer in detergent (Fig. 1F) , and at 3.5 Å resolution for the dimeric ligand complex in LCP (Fig. 1G) .
Each BcTSPO protomer has five transmembrane (TM) a helices organized in clockwise order (TM1-TM2-TM5-TM4-TM3), as viewed from the C-terminal end (Fig. 1, A and B, and fig. S1 ) where a short extra-membranous helix (a 1,2 ) between TM1 and TM2 caps a C-terminal pocket (Fig. 1C) . The electrostatic potential surface defines a transmembrane orientation (Fig. 1C) having its N-terminal end heavily positive, likely cytoplasmic in B. cereus, and its C-terminal end largely negative (Fig. 1D and fig. S4, A to D) . A mapping of sequence conservation onto the molecular surface shows a conservative band between TM2 and TM5, a highly conserved pocket opening between TM1 and TM2, and features more conserved at the C-terminal end than on most of the exterior (Fig. 1E and fig. S4, E to H) .
